BTS recommendations for assessing risk and for managing Mycobacterium tuberculosis infection and disease in patients due to start anti-TNF-alpha treatment

Thorax. 2005 Oct;60(10):800-5. doi: 10.1136/thx.2005.046797. Epub 2005 Jul 29.

Abstract

Guidelines have been compiled by The Joint Tuberculosis Committee of the British Thoracic Society to quantify the risks of reactivation of tuberculosis with anti-tumour necrosis factor alpha (anti-TNF-alpha) treatment. These guidelines are intended to inform respiratory physicians, gastroenterologists, rheumatologists and dermatologists, together with specialist nurses in those disciplines.

Publication types

  • Guideline
  • Practice Guideline
  • Review

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Algorithms
  • Antitubercular Agents / adverse effects
  • Chemical and Drug Induced Liver Injury / etiology
  • Child
  • Child, Preschool
  • Humans
  • Infant
  • Infant, Newborn
  • Middle Aged
  • Mycobacterium tuberculosis*
  • Risk Factors
  • Tuberculosis / drug therapy*
  • Tumor Necrosis Factor-alpha / therapeutic use*

Substances

  • Antitubercular Agents
  • Tumor Necrosis Factor-alpha